Rituximab versus Tocilizumab in anti-TNF inadequate responder patients with Rheumatoid Arthritis (R4RA): a stratified, biopsy-driven, multi-centre, randomised, open label, controlled clinical trial – 16 week outcomes

Frances Humby, Costantino Pitzalis, Maya H Buch et al.|Research Explorer (The University of Manchester)|2020

Cited by 1